Ancora Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.5K | Buy |
137
+22
| +19% | +$3.94K | ﹤0.01% | 1167 |
|
|
2025
Q1 | $19.5K | Buy |
115
+2
| +2% | +$339 | ﹤0.01% | 1186 |
|
|
2024
Q4 | $17.1K | Hold |
113
| – | – | ﹤0.01% | 1228 |
|
|
2024
Q3 | $17.5K | Buy |
113
+2
| +2% | +$310 | ﹤0.01% | 1198 |
|
|
2024
Q2 | $15.2K | Hold |
111
| – | – | ﹤0.01% | 1186 |
|
|
2024
Q1 | $14.7K | Buy |
111
+1
| +0.9% | +$133 | ﹤0.01% | 1216 |
|
|
2023
Q4 | $15.2K | Buy |
110
+1
| +0.9% | +$138 | ﹤0.01% | 1175 |
|
|
2023
Q3 | $13.3K | Hold |
109
| – | – | ﹤0.01% | 1193 |
|
|
2023
Q2 | $15.3K | Buy |
109
+1
| +0.9% | +$140 | ﹤0.01% | 1160 |
|
|
2023
Q1 | $15.3K | Hold |
108
| – | – | ﹤0.01% | 1158 |
|
|
2022
Q4 | $17K | Buy |
108
+1
| +0.9% | +$157 | ﹤0.01% | 1187 |
|
|
2022
Q3 | $13K | Hold |
107
| – | – | ﹤0.01% | 1387 |
|
|
2022
Q2 | $14K | Buy |
107
+1
| +0.9% | +$131 | ﹤0.01% | 1467 |
|
|
2022
Q1 | $15K | Hold |
106
| – | – | ﹤0.01% | 1587 |
|
|
2021
Q4 | $18K | Buy |
106
+1
| +1% | +$170 | ﹤0.01% | 1603 |
|
|
2021
Q3 | $15K | Hold |
105
| – | – | ﹤0.01% | 1534 |
|
|
2021
Q2 | $14K | Buy |
105
+1
| +1% | +$133 | ﹤0.01% | 1416 |
|
|
2021
Q1 | $13K | Hold |
104
| – | – | ﹤0.01% | 1359 |
|
|
2020
Q4 | $12K | Buy |
+104
| New | +$12K | ﹤0.01% | 1135 |
|
|
2018
Q4 | – | Sell |
-375
| Closed | -$40K | – | 748 |
|
|
2018
Q3 | $40K | Buy |
+375
| New | +$40K | ﹤0.01% | 938 |
|
|
2017
Q1 | – | Sell |
-375
| Closed | -$34K | – | 711 |
|
|
2016
Q4 | $34K | Buy |
+375
| New | +$34K | ﹤0.01% | 838 |
|